784P - Nivolumab monotherapy in metastatic urothelial cancer (mUC): Updated efficacy by subgroups and safety results from the CheckMate 032 study
| Autor: | Rosenberg, J.E., Bono, P., Kim, J., Spiliopoulou, P., Calvo, E., Pillai, R., Ott, P.A., de Braud, F., Morse, M., Le, D., Jaeger, D., Chan, E., Harbison, C., Lin, C.S., Tschaika, M., Azrilevich, A., Sharma, P. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi271-vi271 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|